Companies A and B manufacture and market health-care products. One firm is the world's largest prescription-pharmaceutical company. This firm has a very broad and deep pipeline of ethical pharmaceuticals. supported by a robust research and development budget. In recent years, the company has divested several of its nonpharmaceutical deals businesses, and it has come to be seen as the partner of choice for licensing with other pharmaceutical and biotechnology firms.